OOTR-N016 Exploratory Analyses Presented at SABCS 2024

The exploratory analysis results for the OOTR-N016/KBCRN-B-003/PAB-HT trial (NCT03969121) were presented at the 2024 San Antonio Breast Cancer Symposium.

The poster title is: "Subtype by PAM50 Changes After Neoadjuvant Endocrine Therapy: A Phase III Randomized, Double-Blind, Neoadjuvant Study of Hormonal Therapy Plus Palbociclib versus Hormonal Therapy Plus Placebo in Women with Operable, Hormone-Sensitive, and HER2-Negative Primary Breast Cancer" (poster ID: P5-04-28).

This poster presented the exploratory analysis results conducted on the OOTR-N016 trial to understand the biological changes following endocrine therapy (ET), predict the efficacy of ET, and consider potential additional therapies.

For more details, visit: https://sabcs.org/Portals/0/Documents/FINAL%20SABCS%2024%20%20Poster%20Session%205.pdf?ver=22RA4bG_MAJsPyyFxI-RCQ%3D%3D.